The Influence of Fish Consumption on Polyunsaturated Fatty Acid (PUFA) Status

NCT03765580 | Completed

• 1 other identifier: REC/16/0077
• Study Type: interventional
• Target: 49
• Locations: 1 country
• Sites: 1

Brief Summary

Polyunsaturated fatty acids (PUFA) are important for health, for example for the immune system, heart health and the brain. PUFA are found in fish, nuts and oils; including these foods in the diet provides the body with PUFA. The body can also produce some PUFA in a series of steps. It has been found that genetics influences the levels of PUFA produced in the body. This study will investigate whether fish consumption influences PUFA status in women of childbearing age when accounting for FADS genotype by conducting a controlled human intervention study. Participants will be asked to consume none, one or two portions of oily fish per week for 8 weeks and their response in PUFA status measured. This study will also use collected blood, hair, urine and faecal samples collected from the intervention study to explore other biomarkers of fish consumption. The aim of this study is to investigate whether fish consumption influences PUFA status in women of childbearing age when accounting for FADS genotype and to explore the potential of a novel biomarker, using hair MeHg:δ34S values, to accurately predict fish consumption. The study will initially involve providing a buccal swab sample which will investigate genes which are related to fatty acids. The participant will provide a buccal swab sample so that their genotype can be determined. The researcher who will contact the participant once genotype has been determined to arrange a baseline appointment. Participants will attend the Human Intervention Studies Unit at Ulster University, Coleraine once or twice weekly for a period of 8 weeks where they will receive lunch. This lunch will contain either tuna, sardines, or no fish depending on the intervention group you will be allocated to. Examples of lunch time meals they may receive include sandwiches, baked potato or salad which will include the type of fish they have been allocated to receive. Those allocated to the no fish group will receive a fish free alternative lunch. Participants will be asked to continue to follow their normal diet and lifestyle over the intervention period of 8 weeks. All participants will attend a baseline and post intervention appointment where they will have weight, height and body composition measured. Participants will also complete questionnaires to provide medical, lifestyle and dietary information. All participants will be asked to provide a sample of blood, urine, hair and faeces to assess biomarkers of fish consumption at baseline and post intervention appointments. Collected blood, urine, hair and faecal samples will be analysed for biomarkers of fish consumption. Participants will also be asked to return to the Human Intervention Studies Unit (HISU) 8 weeks after the intervention study has been completed (week 16) to provide a third hair sample and complete a Fish Feedback Questionnaire. In the 8 wks following conclusion of the study they will be free to return to their normal diet.

Conditions

Polyunsaturated Fatty Acid (PUFA) Status

Keywords

Polyunsaturated fatty acids (PUFA); fish; fish consumption; women; childbearing age

Outcome Measures

Primary Outcomes (1)

• Polyunsaturated fatty acid (PUFA) status

  Serum Polyunsaturated fatty acid (PUFA) status

  Change at 8 weeks from baseline

Secondary Outcomes (9)

• Hair mercury

  Change at 8 & 16 weeks from baseline

• Lipid profile

  Change at 8 weeks from baseline

• Iodine

  Change at 8 weeks from baseline

• Inflammatory status

  Change at 8 weeks from baseline

• Oxidative stress

  Change at 8 weeks from baseline

Study Arms (3)

Control group

PLACEBO COMPARATOR

No fish

Other: Control

1 portion of fish per week

EXPERIMENTAL

140g fish/week

Dietary Supplement: Fish

2 portions of fish per week

EXPERIMENTAL

280g fish/week

Dietary Supplement: Fish

Interventions

Fish DIETARY_SUPPLEMENT

Lunch containing fish

1 portion of fish per week; 2 portions of fish per week

Control OTHER

Lunch containing no fish

Control group

Eligibility Criteria

• Age: 18 Years - 45 Years
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• Healthy females - premenopausal, child-bearing age, not planning to become pregnant
• Age 18-45years old
• Low consumers of fish (\<2 portions/ week) or those willing to reduce their fish consumption one month prior to commencing the study to the equivalent of 2 portions per month or less
• Willing to eat 1 or 2 portions (140 grams or 280 grams) of either tuna or sardines per week for a period of 8 weeks
• Not consuming fish oil supplements
• Not consuming protein supplements
• Not allergic to seafood

You may not qualify if:

• Regularly eat fish or not willing to do washout period where they reduce fish consumption
• Are allergic to seafood
• Are taking fish oil supplements or are taking protein supplements
• Are pregnant or menopausal
• Have very short hair (a small section of hair, approximately 200 strands, will be taken at the nap of the neck for analysis purposes)

Sponsors & Collaborators

• University of Ulster: lead
• University of Rochester: collaborator
• Lund University: collaborator
• Ministry of Health, Republic of Seychelles: collaborator

Study Sites (1)

Human Intervention Studies Unit, Ulster University

Coleraine, Co.Londonderry, BT52 1SA, United Kingdom

Location

Related Publications (1)

• Conway MC, McSorley EM, Mulhern MS, Spence T, Wijngaarden EV, Watson GE, Wahlberg K, Pineda D, Broberg K, Hyland BW, Cobice DF, Strain JJ, Yeates AJ. The influence of fish consumption on serum n-3 polyunsaturated fatty acid (PUFA) concentrations in women of childbearing age: a randomised controlled trial (the iFish Study). Eur J Nutr. 2021 Apr;60(3):1415-1427. doi: 10.1007/s00394-020-02326-w. Epub 2020 Jul 28.

  PMID: 32725293 DERIVED

MeSH Terms

Interventions

In Situ Hybridization, Fluorescence

Intervention Hierarchy (Ancestors)

In Situ Hybridization; Staining and Labeling; Histocytological Preparation Techniques; Cytological Techniques; Clinical Laboratory Techniques; Diagnostic Techniques and Procedures; Diagnosis; Histological Techniques; Investigative Techniques; Cytogenetic Analysis; Genetic Techniques; Nucleic Acid Hybridization

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: PREVENTION
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: December 4, 2018
• First Posted: December 5, 2018
• Study Start: September 1, 2016
• Primary Completion: May 31, 2017
• Study Completion: May 31, 2017
• Last Updated: December 5, 2018

Record last verified: 2018-12

Locations

GB (1)